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Cyclooxygenase (COX)-2 and neuronal nitric oxide (NO) synthase (NOS1) are involved in the control of afferent vascular tone (19) , and an increase in their expression in the macula densa has been associated with renal damage (13, 32) . It has also been proposed that an elevation in COX-2 activity is involved in the renal adaptation to a reduced nephron endowment (23) and that an increase in glomerular capillary pressure occurs as a consequence of a selective reduction in afferent arteriolar resistance, with no change or an increase in efferent resistance (21, 23) . Considering that renal function is much more affected at adult and advanced ages in males than in females with reduced nephron endowment (4, 22, 25, 26) , another hypothesis tested was that COX-2 and NOS1 are enhanced in the macula densa of males but not females with an adverse event during renal development.
MATERIALS AND METHODS
Sprague-Dawley rats were purchased from the Laboratory Animals Service of the University of Murcia. This study was approved by the University of Murcia Review Committee, and experiments were designed according to the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. Rats had free access to normal rat chow and tap water and were kept in rooms with a controlled temperature (24°C). Female rats (230 -240 g body wt) were placed with a fertile male, and day 0 of pregnancy was taken as the morning that evidence of sperm was found in a vaginal smear. Newborn rats were treated during postnatal days 1-14 with vehicle (isotonic saline) or an ANG II type 1 (AT 1) receptor antagonist (L-158.809, Merck, Sharp & Dohme) at an oral dose of 7 mg·kg Ϫ1 ·day Ϫ1 . This treatment leads to a similar nephron number reduction in both sexes (25) .
Systolic BP. Systolic BP was measured by the tail-cuff method using a CODA 2 noninvasive system (21-23, 27) at 10 -11 and 16 -17 mo of age in control male rats, control female rats, and male and female rats treated with the AT 1 receptor antagonist during the nephrogenic period (ARAnp rats; n ϭ 8 rats/group from at least 5 litters). Systolic BP values obtained using the tail-cuff method are highly correlated with those obtained in conscious freely moving rats using an indwelling catheter in the femoral artery (27) . One week after BP measurements were completed, rats were anesthetized (pentothal sodium, 5 mg/100 g body wt), and both kidneys were removed. Left kidneys were used for morphological experiments, and right kidneys were stored at Ϫ70°°C until processed for Western blot analysis.
Renal function. After an overnight fast, rats were anesthetized (pentobarbital sodium and ketamine) and surgically prepared (14, 21-23, 25, 27 ) with catheters into the bladder for the collection of urine samples, into the left femoral artery for mean arterial pressure measurement (PowerLab) and blood withdrawal, and into the left femoral vein for intravenous infusions. [ 3 H]inulin (2 Ci/ml, American Radiolabeled Chemicals) was given as an intravenous bolus (1 ml) and as a continuous infusion (1.5 Ci/ml) dissolved in isotonic saline (1 ml·100 g body wt Ϫ1 ·h Ϫ1 ). Clearances of [ 3 H]inulin were analyzed to measure the glomerular filtration rate (GFR). A transittime flow probe (Transonic) was implanted on the left renal artery for renal blood flow measurements. After a 60-min equilibration period, two 20-min clearances were obtained. Rats from at least five litters were included in each group.
Renal COX-2, NOS1, and endothelial NO synthase expression. The renal cortex was dissected and homogenized. Protein (50 g) was separated on 4 -20% SDS-PAGE gels (Bio-Rad) and transferred to a nitrocellulose membrane (Hybond ECL, Amersham). Primary antibodies against COX-2 (Cayman), NOS1 and endothelial NO synthase (NOS3; Santa Cruz Biotechnology), and GAPDH (Sigma) were used. Proteins were normalized against GADPH expression. Bound antibody was detected using a horseradish peroxidase-conjugated antibody (Santa Cruz Biotechnology). Bands were visualized using an enhanced chemiluminescence system (ECL Plus, Amersham), and images were captured on autoradiography film, scanned, and quantified with the ImageJ program (NIH). Expression in male and female rats was examined on the same gels to determine whether there were sex-dependent differences in this expression.
Morphological and immunohistochemical experiments. Left kidneys were sliced into 2-mm-thick slices and then fixed in 10% formaldehyde in PBS (pH 7.4). Kidney slices were embedded in paraffin. Blocks were sectioned at 4 m using a HM310 microtome (Microm). Sections were stained with hematoxylin-eosin, Masson's trichome, and periodic acid-Schiff. Volumes of the cortex and medulla were estimated by the Cavalieri principle (25) . Glomerular volumes were obtained in Masson's trichrome-stained sections (25, 26) .
To determine glomerular damage, glomerular profiles were examined and assigned to one of four groups according to the degree of damage (25, 26) . Approximately 500 glomerular profiles were examined in each group. Tubulointerstitial injury was scored (25, 26) using MIP 4.5 image-analysis software (Consulting Image Digital) in sections stained with Masson's trichrome and viewed on a PC screen at ϫ285 magnification. From each kidney zone and experimental group, 50 fields were examined. Another subset of 10-to 11-mo-old rats (n ϭ 4 rats/group from 4 different litters) was used for the immunohistochemical and ultrastructure experiments. After perfusion fixation, kidneys were removed and processed (12) for further analysis. Cryostat sections (5 m thick) were cut for NOS1 and COX-2 immunostaining. Immunolabeling of ␣-actin was examined using an antibody against ␣-smooth muscle actin (1:200 dilution, DakoCytomation). The percentage of glomeruli showing ␣-actin was evaluated using Leica Qwin (version 3.0) imageanalysis software. Twenty glomeruli were evaluated per animal. For NOS1 immunostaining, an antibody directed against amino acids 1-181 of rat NOS1 (Sigma) was used at 1:100 dilution. COX-2 immunostaining was performed using an antibody directed against amino acids 584 -598 of murine COX-2 (Cayman) at 1:250 dilution. After an overnight incubation, bound antibody was visualized with Cy2-or Cy3-labeled secondary antibody (Jackson Laboratories). Sections were examined using a Leica DMRB microscope with an epifluorescence module. Images were acquired using a SPOT RT 2.3.0 digital camera (Diagnostic Instruments) and the MetaVue imaging system (Molecular Devices). Immunoreactive signals for NOS1 and COX-2 were quantified by counting stained macula densa cells and normalized for the total number of glomeruli (19) . Numbers of COX-2-immunoreactive cells in the thick ascending limb of Henle (TALH) per section were obtained as well.
For fine structural analysis, kidney slices were postfixed overnight in a solution containing 1.5% glutaraldehyde, 1.5% paraformaldehyde, and 0.05% picric acid in 0.1 M Na-cacodylate (pH 7.4). After being Epon embedded, 1-m semithin sections were stained with Richardson's solution. For electron microscopic experiments, ultrathin sections were stained with uranyl acetate and lead citrate and analyzed with a Zeiss EM 900 electron microscope (28) .
Statistical analysis. All values are presented as means Ϯ SE. Statistical differences in each parameter were examined using GB Stat (Dynamic Microsystems). Two-way ANOVA was used to evaluate differences between groups. P values of Ͻ0.05 were considered statistically significant. Table 1 shows that BP was similar in both sexes and at both ages in control rats. Table 1 also shows that BP was elevated at 10 -11 mo and that there was a further increment (P Ͻ 0.05) with age in both sexes of ARAnp-treated rats. BP was greater (P Ͻ 0.05) in male than female ARAnp-treated rats at both ages.
RESULTS

BP.
Renal function. Renal hemodynamics were similar in both sexes and at both ages in control rats (Table 2 ). Both GFR and renal plasma flow (RPF) were reduced (P Ͻ 0.05) in male but not female ARAnp-treated rats at 10 -11 mo of age and were reduced (P Ͻ 0.05) in both sexes of ARAnp-treated rats at 16 -17 mo of age. As shown in Table 2 , there was an agedependent reduction of GFR and RPF in both sexes of ARAnptreated rats. Renal vascular resistance was enhanced in both sexes of ARAnp-treated rats and increased between 10 -11 and 16 -17 mo of age in these hypertensive rats. This increment in renal vascular resistance was greater (P Ͻ 0.05) in male than female ARAnp-treated rats (Table 2) .
Renal COX-2, NOS1, and NOS3 expression. Expression of renal COX-2, NOS1, and NOS3 is shown in Fig. 1 and Table  3 as fold expression found in control male rats. COX-2 expression was similarly elevated (P Ͻ 0.05) in the renal cortex of male and female ARAnp-treated rats at 10 -11 (Table 3 ) and 16 -17 ( Fig. 1 ) mo of age. However, no significant differences in NOS1 expression were found between ARAnp-treated and control rats at both ages (Table 3 and Fig. 1 ). NOS3 expression was reduced (P Ͻ 0.05) in male but not female ARAnp-treated rats at 10 -11 mo of age (Table 3 ) with respect to the expression found in their respective control rats. NOS3 expression Values are means Ϯ SE; n, no. of rats/group. COX-2, cyclooxygenase 2; NOS1, neuronal nitric oxide synthase; NOS3, endothelial nitric oxide synthase. *P Ͻ 0.05 vs. control rats of the same sex; †P Ͻ 0.05 vs. female rats of the same age and with the same treatment.
was similar in ARAnp-treated and control rats at 16 -17 mo of age ( Fig. 1) .
Morphological and immunohistochemical experiments. Table 4 shows that glomerular volume was increased (P Ͻ 0.05) at both ages in ARAnp-treated rats and was greater (P Ͻ 0.05) in male rats than in female rats. Glomerular volume increased (P Ͻ 0.05) between both ages in control but not ARAnptreated rats. As shown in Table 4 , cortical and outer medullary volumes were greater (P Ͻ 0.05) in male rats than in female rats. At 10 -11 mo of age, these renal volumes were similar in male ARAnp-treated and control rats but greater (P Ͻ 0.05) in female ARAnp-treated than control rats. Inner medullary volume was reduced (P Ͻ 0.05) at 10 -11 mo in male but not female ARAnp-treated rats. At 16 -17 mo of age, cortical and medullary volumes were greater (P Ͻ 0.05) in male and female ARAnp-treated rats than in their respective control groups, and inner medulla volume was reduced (P Ͻ 0.05) in both sexes of ARAnp-treated rats (Table 4 ). Figure 2 shows that glomerular volume distribution was clearly sex dependent in control and ARAnp-treated rats. At 10 -11 mo of age, the volumes of most glomeruli (92 Ϯ 3%) were similarly distributed within the four larger-sized groups in control male rats. However, at the same age, most glomeruli in control female rats had volumes between Ͻ5 ϫ 10 5 m 3 (52 Ϯ 6%) and 5-7.5 ϫ 10 5 m 3 (42 Ϯ 4%). A decrease in the percentage of smaller glomeruli and an increase in the percentage of larger glomeruli were found in male ARAnp-treated rats. Similar changes were found in female ARAnp-treated 
Values are means Ϯ SE; n ϭ 8 rats/group. *P Ͻ 0.05 vs. control rats of the same sex; †P Ͻ 0.05 vs. female rats of the same age and with the same treatment; ‡P Ͻ 0.05 vs. 10-to 11-mo-old rats of the same sex and with the same treatment. rats, but the percentage of glomeruli with the greatest volume range (Ͼ12.5 ϫ 10 5 m
3
) was higher in male (75 Ϯ 5%) than female (39 Ϯ 11%) ARAnp-treated rats. Significant changes in glomerular volume distribution were found between 10 -11 and 16 -17 mo of age in control rats. The volume of most glomeruli (81 Ϯ 7%) was Ͼ10 6 m 3 in control male rats at 16 -17 mo of age. Glomerular volumes in control female rats at the same age were similarly distributed between the five sizes. As shown in Fig. 2 , the percentage of glomeruli with the greatest volume range (Ͼ12.5 ϫ 10 5 m 3 ) was higher (P Ͻ 0.05) in ARAnp-treated than control rats at 16 -17 mo of age.
Glomerulosclerosis was slightly greater (P Ͻ 0.05) in control male than female rats at both ages and did not change with time (Table 5 ). At 10 -11 mo, there was an elevation (P Ͻ 0.05) of glomerulosclerosis in both sexes of ARAnp-treated rats, but the increase in glomerular damage was greater (P Ͻ 0.05) in male than female ARAnp-treated rats. An age-dependent increment in glomerulosclerosis was found in both sexes of ARAnp-treated rats, but the glomerular damage at 16 -17 mo of age was much more severe in male rats than in female rats (Table 5) . Tubulointerstitial damage was similar in control male and female rats at 10 -11 mo and increased (P Ͻ 0.05) with time in the outer and inner cortex of control male but not female rats (Table 6 ). As occurred with glomerulosclerosis, tubulointerstitial damage was enhanced (P Ͻ 0.05) in ARAnptreated rats, with the damage being age dependent and much more severe in male rats. Figure 3 shows that the percentage of ␣-actin-immunoreactive glomeruli was enhanced at both ages in male ARAnptreated rats. There were no differences between both control groups, whereas male ARAnp-treated rats showed a higher percentage (P Ͻ 0.05) of affected glomeruli compared with female ARAnp-treated rats at both ages. Numbers of immunoreactive glomeruli increased with age (P Ͻ 0.05) in ARAnptreated rats but not in control rats (Figs. 3 and 4) .
Numbers of immunoreactive cells for COX-2 in glomeruli and TALH was greater (P Ͻ 0.05) in ARAnp-treated rats than in control rats at 10 -11 mo of age (Table 3 and Fig. 5) . A sex-dependent difference was found since COX-2 immunostaining in glomeruli and TALH was more frequent (P Ͻ 0.05) in both groups of male rats compared with both groups of female rats. Numbers of immunoreactive cells for COX-2 and NOS1 in the macula densa were enhanced (P Ͻ 0.05) in male but not female ARAnp-treated rats at 10 -11 mo of age with respect to the values found in their respective control groups (Table 3 ). In addition to the tubular COX-2 staining, a strong accumulation of COX-2 in the cytoplasm of infiltrating leukocytes was also observed in ARAnp-treated rats. Analysis of male and female rats revealed no sex-dependent differences in Values are means Ϯ SE; n ϭ 8 rats/group. *P Ͻ 0.05 vs. control rats of the same sex; †P Ͻ 0.05 vs. female rats of the same age and with the same treatment; ‡P Ͻ 0.05 vs. 10-to 11-mo-old rats of the same sex and with the same treatment. the extent of interstitial COX-2 abundance at 10 -11 mo of age (Fig. 6 ). Fine structural analysis revealed extensive glomerular and tubular damage as well as tubuloinsterstitial infiltration of leukocytes in 10-to 11-mo-old male ARAnp-treated rats (Fig.  6) . Damage was greater in male than female ARAnp-treated rats. Glomerular damage included a marked thickening of the basement membrane and a detachment of endothelial cells from this membrane. The periglomerular accumulation of activated fibroblasts observed corroborates the results of the ␣-actin immunostaining of myofibroblasts at 10 -11 mo of age. Tubular damage included extensive vacuolization as well as a protrusion of tubular cells into the lumen. Profiles of damaged tubular cells were filled with large lysosomes, thus reflecting the increased endocytotic and autophagic activity. A marked expansion of the tubulointerstitium due to an accumulation of activated fibroblasts and infiltrating leukocytes as well as an augmented deposition of extracellular matrix components was also observed in 10-to 11-mo-old male ARAnp-treated rats (Fig. 6) .
DISCUSSION
In the present study, novel findings showing to what extent BP increases and renal function and renal structure are deteriorated in aged animals with a significant impairment of renal development are reported. This study also shows to what extent aged females are more protected than their male counterparts from the increment in BP and deterioration of renal structure and function secondary to altered renal development. The possible association between these renal changes with those in COX-2 and NOS1 expression in the renal cortex and their immunoreactivity in the glomerulus, TALH, and macula densa was also examined.
The increase of BP in ARAnp-treated rats is similar in both sexes at 3-4 mo of age (21, 23, 25) , but only male rats had a further increment in BP between 3-4 and 10 -11 mo of age (21, 23) . This study extends our previous observations by showing that there is a greater elevation of BP in both sexes of ARAnp-treated rats but not control rats between 10 -11 and 16 -17 mo of age and that BP remains greater in male than female ARAnp-treated rats. The higher BP found in male rats may partly explain the sex differences in renal damage and most probably contributes to the greater mortality rate in male (56%) than female (10%) ARAnptreated rats between both ages. The results reported in this study do not allow us to determine the mechanisms involved, but it may be expected that the BP increment in male rats is secondary to a greater loss of functional nephrons, to a decrease in the ability to maintain Na ϩ balance (15) , and to greater ANG II effects (21) . The involvement of ANG II is supported by a study (21) by our group showing that both renal AT 1 receptor expression and the decrease in BP elicited by AT 1 receptor blockade are greater in male than female ARAnp-treated rats.
Previous studies have demonstrated that there are sexdependent differences in renal function in several models of developmental programming of hypertension (3, 4, 18, 22, 25) . However, it has not been well defined to what extent renal hemodynamics are affected at an old age in male and female animals with altered renal development. This study reports novel findings showing that there is a further alteration of renal hemodynamics at an old age in male ARAnptreated rats since RPF and GFR were reduced by 66% and 74%, respectively. Another new finding is that renal hemodynamics can be maintained within normal levels at an advanced but not at an old age in female rats when renal development is altered since RPF and GFR decreased by 23% and 32%, respectively, at 16 -17 mo of age in female ARAnp-treated rats (Table 2 ). These age-dependent changes of renal hemodynamics in both sexes of ARAnp-treated rats most probably occur as a consequence of the previously reported 37% reduction in nephron number that is similar in both sexes (25) . Changes of renal hemodynamics at an old age could also be partly secondary to the significant elevation in BP and to other effects elicited by the decrease of ANG II levels during the nephrogenic period (17) .
The increase of COX-2 expression in the renal cortex of ARAnp-treated rats seems to occur as a late adaptation to the decrease in nephron endowment and/or the prolonged elevation in BP because COX-2 expression was enhanced at 10 -11 mo of age but not at 3-4 mo of age (23) . The results of this study extend those previously reported by showing that COX-2, but not NOS1 or NOS3, expression is elevated in the renal cortex of aged ARAnp-treated rats. Other novel findings are that COX-2 and NOS1 immunoreactivity is increased in the macula densa of male but not female ARAnp-treated rats and that COX-2 immunoreactivity in the glomerulus and TALH is elevated in both sexes of ARAnp-treated rats. The enhanced renal vasoconstriction found in male and female ARAnp-treated rats in response to COX-2 inhibition (23) may be explained by these changes in COX-2 immunoreactivity. Based on previous studies showing that an increase of COX-2 and NOS1 in the macula densa is associated with renal damage (13, 31, 32) , it is possible that the sex-dependent evolution of renal disease in ARAnp-treated rats is partly secondary to a greater increment of COX-2 and NOS1 activity in the macula densa of these male rats. An increment in their activity would be accompanied by an elevated production of prostaglandins and NO, and these vasodilatory molecules would induce a decrease of preglomerular resistance. One could also expect that a greater efferent arteriolar tone, secondary to an enhanced sensitivity to ANG II (21) and to a decrease in NOS3 (Table 3) at an advanced age, could also be involved in the renal damage found in male ARAnp-treated rats. However, the hypothesis that male ARAnp-treated rats have a reduced preglomerular resistance and an increase in glomerular capillary pressure seems to be incorrect since the filtration fraction was similar in male and female ARAnptreated rats and was also similar in normotensive and hy- pertensive rats at both ages. Further studies are needed to examine whether the enhanced COX-2 and NOS1 immunoreactivity in the macula densa is involved in the greater renal damage found at an old age in male rats than in female rats with altered renal development.
There is an apparent discrepancy between the reported data on NOS1 at 10 -11 mo of age since total NOS1 expression was not elevated in the renal cortex of ARAnp-treated male rats but NOS1 immunoreactivity was elevated in their macula densa. However, most probably NOS1 expression is also enhanced in the macula densa since the nephron number is reduced in these rats. Our results do not allow us to define the mechanisms involved in the increase of NOS1 and COX-2 in the macula densa of male ARAnp-treated rats, but it may be speculated that the increase in COX-2 is secondary to a greater oxidative stress and greater RAS activation in male rats than in female rats. In support of this possibility, previous studies have shown that renal oxidated proteins and renal AT 1 receptor expression are greater in male than female ARAnp-treated rats (21) and that stimulation of the RAS and oxidative stress enhance COX-2 expression (8) .
To evaluate whether all glomeruli increased similarly their volume to compensate for the fall in glomeruli number and to maintain total GFR, glomerular volumes were distributed in five sizes in each group. The important heterogeneity of glomerular volume in normotensive rats was expected because similar results have been reported in rats (20) and in normotensive and hypertensive subjects (7) . However, as far as we know, there are no studies reporting changes in glomerular volume heterogeneity during aging in both sexes of normotensive animals. It was also unknown whether the glomerular hypertrophy secondary to a reduction in nephron endowment occurs simultaneously in all nephrons during aging and whether these changes in glomerular volume are sex dependent. A novel finding of this study is that normotensive rats showed a certain degree of heterogeneity in the increment of glomerular volume during aging and that the pattern in this increment was sex dependent (Fig. 2) . The results shown in Table 4 extend our previous observations (25) by showing that glomerular volume is already at a maximum level at 10 -11 mo of age in ARAnp-treated rats, with volumes being 62% greater in male than female rats. The mechanisms involved in the marked sex-dependent difference in the age-dependent evolution of glomerular volume in normotensive animals, and when there is an alteration of renal development, remain to be examined. Another remarkable novel finding is the dramatic sexdependent difference in the evolution of renal damage during aging when ANG II effects have been reduced during renal development. The glomerular damage would be responsible for the greater proteinuria in male than female ARAnp-treated rats, which was previously reported by our group (23, 27) . This proteinuria would contribute to the progressive destruction of the remaining nephrons and finally to the reduction of GFR and RPF in aged male ARAnp-treated rats. The pronounced glomerular damage in male ARAnp-treated rats is consistent with reports in patients with unilateral renal agenesis (11) and was confirmed in electron microscopic experiments, which showed a marked thickening of the glomerular basement membrane and a periglomerular accumulation of activated fibroblasts (Fig. 6) . The enhanced glomerular COX-2 immunoreactivity may be related to the glomerular damage found in these rats since an increase in COX-2 has been proposed to contribute to a variety of glomerular injuries in several models of kidney failure (24) . As a consequence of the progressive sclerosis, some glomeruli fail and nonfunctional and poorly functioning units emerge. The remaining glomeruli then need to hyperfilter, and, as a consequence, a vicious cycle of progressive renal injury occurs that would be responsible for the accelerated greater decrease of GFR and RPF in male rats than in female rats. The sex-dependent difference in glomerular damage could be related to the fact that most glomeruli in male rats have already a maximal volume at 10 -11 mo of age. However, as proposed by Esposito et al.
(1), glomerular hypertrophy and glomerulosclerosis are not necessarily linked. This notion is supported by the fact that glomerular volume increased in male (73%) and female (67%) control rats between 10 -11 and 16 -17 mo of age but glomerulosclerosis did not change between these ages (Tables 4 and 5).
The greater tubulointerstitial damage during aging in male than female ARAnp-treated rats may be partly secondary to the sex-dependent differences in glomerulosclerosis and proteinuria (27) . Tubular damage included extensive vacuolization as well as a protrusion of tubular cells into the lumen (Fig. 6) . Electron microscopic examination also showed a marked expansion of the tubulointerstitium due to an accumulation of activated fibroblasts and infiltrating leukocytes as well as an augmented deposition of extracellular matrix components. This renal tubulointerstitial inflammation secondary to the observed immune cell infiltration and tubular COX-2 activation may be involved in the development of Na ϩ -sensitive hypertension in ARAnptreated rats (2, 27) . The important infiltration of leukocytes in male ARAnp-treated rats most probably also plays an essential role in the pathogenesis of the accelerated progression of renal disease in these rats (10) .
Some regulatory mechanisms triggered by factors such oxidative stress and gonadal steroids may also be involved in the sex-dependent evolution of renal damage during aging. The involvement of oxidative stress has been supported by studies showing that chronic renal failure is associated with an increase of oxidative stress in male rats (29) and that renal oxidative stress is greater in male than female ARAnp-treated rats at 10 -11 mo of age (21) . Sex steroids were not measured in this study, but it is suggested that they may also play an important role in the renal protection in female ARAnp-treated rats before 11 mo of age. This hypothesis is supported by studies showing that the estrous cycle stops at 12 mo in rats (16, 34) and by our previous results demonstrating that BP increases and renal function progressively deteriorates between 3-4 and 10 -11 mo of in male but not female ARAnp-treated rats (21, 23) . The absence of renal protection by sex steroids in female ARAnp-treated rats would be evident at 16 -17 mo of age because they have a further increment in BP and a progressive deterioration of renal function and renal structure between 10 -11 and 16 -17 mo of age. The importance of sex hormones seem to be related to their effects on other mechanisms since female sex hormones reduce renal inflammation and oxidative stress (9, 35) and downregulate renal AT 1 receptors (6) .
In summary, this study reports novel findings showing that an alteration of renal development leads to a progressive and continuous increment of BP and to the deterioration of renal function and renal structure in male and female rats at an old age. New findings also suggest that increases in the COX-2 and NOS1 activity in the macula densa play an important role in the greater renal damage found at an old age in male rats than in female rats with altered renal development. These results may have important pathophysiological and clinical implications since new findings are reported showing that a decrease of ANG II effects during the nephrogenic period leads to a progressive increment in BP and to renal damage in both sexes at an old age. These results are important since RAS activity also decreases in situations that are not uncommon in humans, such as the administration of glucocorticoids or a low-protein diet in pregnant women or as a consequence of placental insufficiency (3, 5, 18, 30) . New studies are needed to examine age-dependent BP and renal changes in the offspring of mothers with placental insufficiency or of mothers treated with glucocorticoids or a low-protein diet during the nephrogenic period. 
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